T1	Phenotype	48 76	high level MET amplification
T2	Limited_variation	82 101	wild-type PIK3CA or
T3	Limited_variation	102 161	MET exon 14 skipping mutation with PIK3CA - p.Glu542Lys had
T4	Pharmacodynamic_phenotype	174 210	responses to crizotinib ; suggesting
T5	Limited_variation	216 238	PIK3CA co-mutation did
T6	Pharmacodynamic_phenotype	268 269	.
R1	isAssociatedWith	Arg1:T1	Arg2:T2
R2	isAssociatedWith	Arg1:T1	Arg2:T3
R3	isAssociatedWith	Arg1:T1	Arg2:T4
R4	isAssociatedWith	Arg1:T1	Arg2:T5
R5	isAssociatedWith	Arg1:T1	Arg2:T6
R6	isAssociatedWith	Arg1:T2	Arg2:T1
R7	isAssociatedWith	Arg1:T2	Arg2:T3
R8	isAssociatedWith	Arg1:T2	Arg2:T4
R9	isAssociatedWith	Arg1:T2	Arg2:T5
R10	isAssociatedWith	Arg1:T2	Arg2:T6
R11	isAssociatedWith	Arg1:T3	Arg2:T1
R12	isAssociatedWith	Arg1:T3	Arg2:T2
R13	isAssociatedWith	Arg1:T3	Arg2:T4
R14	influences	Arg1:T3	Arg2:T5
R15	isAssociatedWith	Arg1:T3	Arg2:T6
R16	isAssociatedWith	Arg1:T4	Arg2:T1
R17	isAssociatedWith	Arg1:T4	Arg2:T2
R18	isAssociatedWith	Arg1:T4	Arg2:T3
R19	influences	Arg1:T4	Arg2:T5
R20	influences	Arg1:T4	Arg2:T6
R21	influences	Arg1:T5	Arg2:T1
R22	influences	Arg1:T5	Arg2:T2
R23	influences	Arg1:T5	Arg2:T3
R24	influences	Arg1:T5	Arg2:T4
R25	influences	Arg1:T5	Arg2:T6
R26	isAssociatedWith	Arg1:T6	Arg2:T1
R27	isAssociatedWith	Arg1:T6	Arg2:T2
R28	isAssociatedWith	Arg1:T6	Arg2:T3
R29	isAssociatedWith	Arg1:T6	Arg2:T4
R30	isAssociatedWith	Arg1:T6	Arg2:T5
